Cardiovascular Effects of Juniperus excelsa Are Mediated Through Multiple Pathways

REFERENCES

• Shanjani PS. Nitrogen effect of callus induction and plant regeneration of Juniperus excelsa. Int J Agric Biol 2003; 5:419–422.
   Google Scholar
• Emami SA, Asili J, Mohagheghi Z, Hassanzadeh MK. Antioxidant activity of leaves and fruits of Iranian conifers. Evid Based Complement Alternat Med 2007; 4:313–319.
   PubMed Web of Science ®Google Scholar
• Kaul MK. Medicinal Plants of Kashmir and Ladakh: Temperate and Cold Acrid Himalaya. New Delhi: Indus Publishing Company, 1997:173.
   Google Scholar
• Usmanghani K, Saeed A, Alam MT. Indusyunic Medicine. Karachi: University of Karachi Press, 1997:468–469.
   Google Scholar
• Nadkarni KM. Indian Materia Medica. Bombay: Popular Prakashan, 1976:713.
   Google Scholar
• Baquar SR. Medicinal and Poisonous Plants of Pakistan. Karachi: Printas, 1989:248–249.
   Google Scholar
• Cakilcioglua U, Khatunb S, Turkogluc I, Haytad S. Ethnopharmacological survey of medicinal plants in Maden (Elazig-Turkey). J Ethnopharmacol 2011; 137:469–486.
   Google Scholar
• Kapoor LD. Handbook of Ayurvedic Medicinal Plants. Boca Raton: CRC Press, 1990:215.
   Google Scholar
• Thappa RK, Aggarwal SG, Kapahi BK, Sarin YK. Juniperus excelsa leaf oil, a new source of cedrol. J Nat Prod 1987; 50:323–324.
   Web of Science ®Google Scholar
• Adams RP. The chemical composition of leaf oils of Juniperus excelsa M. Bieb. J Essent Oil Res 1990; 2:45–48.
   Google Scholar
• Unlu M, Unlu GV, Vural N, Donmez E, Cakmak O. Composition and antibacterial activity of Juniperus excelsa essential oil. Chem Nat Comp 2008; 44:129–131.
   Web of Science ®Google Scholar
• Topçu G, Erenler R, Cakmak O, . Diterpenes from the berries of Juniperus excelsa. Phytochemistry 1999; 50:1195–1199.
   PubMed Web of Science ®Google Scholar
• Sokovic MD, Ristic M, Grubi D. Chemical composition and antifungal activity of the essential oil from Juniperus excelsa berries. Pharm Biol 2004; 44:328–334.
   Web of Science ®Google Scholar
• Ozturk M, Tumen I, Ugur A, Aydogmuş-Ozturk F, Topçu G. Evaluation of fruit extracts of six Turkish Juniperus species for their antioxidant, anticholinesterase and antimicrobial activities. J Sci Food Agric 2011; 91:867–876.
   PubMed Web of Science ®Google Scholar
• Khan M, Khan A, Gilani AH. Pharmacological explanation for the medicinal use of Juniperus excelsa in hyperactive gut and airways disorders. J Nat Med 2011, accepted.
   Google Scholar
• Williamson EM, Okpako DT, Evans FJ. Selection, Preparation and Pharmacological Evaluation of Plant Material. Vol. 1. Chichester: Wiley; 1998:15–23.
   Google Scholar
• National Research Council. Guide for the Care and Use of Laboratory Animals. Washington: National Academy Press, 1996:1–7.
   Google Scholar
• Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol 2005; 4:685–688.
   Web of Science ®Google Scholar
• Gilani SN, Khan A, Gilani AH. Pharmacological basis for the medicinal use of Zanthoxylum armatum in gut, airways and cardiovascular disorders. Phytother Res 2010; 24:553–558.
   PubMed Web of Science ®Google Scholar
• Consolini AE, Baldini OAN, Amat AG. Pharmacological basis for the empirical use of Eugenia uniflora L. (Myrtaceae) as antihypertensive. J Ethnopharmacol 1999; 66:33–39.
   PubMed Web of Science ®Google Scholar
• Khan A, Gilani AH. Blood pressure lowering, cardiovascular inhibitory and bronchodilatory activities of Achillea millefolium. Phytother Res 2011; 25:577–583.
   PubMed Web of Science ®Google Scholar
• Sahin AS, Bariskaner H. The mechanisms of vasorelaxant effect of leptin on isolated rabbit aorta. Fundam Clin Pharmacol 2007; 21:595–600.
   PubMed Web of Science ®Google Scholar
• Van-Rossum JM. Cumulative concentration-response curves. II. Techniques for the making of concentration-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 1963; 143:299–330.
   PubMedGoogle Scholar
• Pietrobon D, Hess P. Novel mechanism of voltage-dependent gating in L-type calcium channels. Nature 1990; 346:651–655.
   Google Scholar
• Godfraind T, Salomone S, Dessy C, Verhelst B, Dion R, Schoevaerts JC. Selectivity scale of calcium antagonists in the human cardiovascular system based on in-vitro studies. J Cardiovasc Pharmacol 1992; 20:S34–S41.
   PubMed Web of Science ®Google Scholar
• Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol 2005; 45:74–80.
   PubMed Web of Science ®Google Scholar
• Karaki H, Ozaki H, Hori M, . Calcium movements, distribution and functions in smooth muscle. Pharmacol Rev 1997; 49:157–230.
   PubMed Web of Science ®Google Scholar
• Cao YX, Zheng JP, He JY, Li J, Xu CB, Edvinsson L. Induces vasodilation of rat mesenteric artery in-vitro mainly by inhibiting receptor-mediated Ca+2 influx and Ca+2-release. Arch Pharm Res 2005; 28:709–715.
   PubMed Web of Science ®Google Scholar
• Khan A, Gilani AH. Cardiovascular inhibitory effects of Hyoscyamus niger. Methods Find Exp Clin Pharmacol 2008; 30:295–300.
   PubMed Web of Science ®Google Scholar
• Shah AJ, Gilani AH. Blood pressure lowering and vascular modulator effects of Acorus calamus extract are mediated through multiple pathways. J Cardiovasc Pharmacol 2009; 54:38–46.
   PubMed Web of Science ®Google Scholar
• Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373–376.
   PubMed Web of Science ®Google Scholar
• Vanhoutte PM, Rubanyi GM, Miller VM, Houston DS. Modulation of vascular smooth muscle contraction by endothelium. Annu Rev Physiol 1986; 48:307–330.
   PubMed Web of Science ®Google Scholar
• Taqvi SIH, Shah AJ, Gilani AH. Blood pressure lowering and vasomodulator effects of piperine. J Cardiovasc Pharmacol 2008; 52:452–458.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Masumiya H, Sekine T, . Myocardial and vascular effects of efonidipine in-vitro as compared with nifidipine, verapamil and diltiazem. Gen Pharmacol 1996; 27:451–454.
   PubMedGoogle Scholar
• Khan A, Gilani AH. Pharmacodynamic evaluation of Terminalia bellerica for its antihypertensive effect. J Food Drug Anal 2008; 16:6–14.
   Web of Science ®Google Scholar
• Ghayur MN, Gilani AH, Afridi MB, Houghton PJ. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vasc Pharmacol 2005; 43:234–241.
   PubMed Web of Science ®Google Scholar
• Ajay M, Chai HJ, Mustafa AM, Gilani AH, Mustafa MR. Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces. J Ethnopharmacol 2007; 109:388–393.
   PubMed Web of Science ®Google Scholar
• Okmura K, Ichihara K, Nagaska M, Oda N, Tajima K. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites. Eur J Pharmacol 1993; 235:69–74.
   PubMed Web of Science ®Google Scholar
• Ajay M, Gilani AH, Mustafa MR. Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 2003; 74:603–612.
   PubMed Web of Science ®Google Scholar
• Ajay M, Achike FI, Mustafa AM, Mustafa MR. Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aorta: comparative study with ascorbic acid. Clin Exp Pharmacol Physiol 2006; 33:345–350.
   PubMed Web of Science ®Google Scholar
• Fleckenstein A. Specific pharmacology of Ca++ in myocardium, cardiac pacemakers and vascular smooth muscle. Annu Rev Pharmacol Toxicol 1977; 17:149–166.
   PubMed Web of Science ®Google Scholar
• Rang HP, Dale MM, Ritter JM. Pharmacology. 4th ed. New York: Churchill Livingstone, 1999:289–290.
   Google Scholar
• Bolton TB. Mechanism of action of transmitters and other substances on smooth muscles. Physiol Rev 1979; 59:606–718.
   PubMed Web of Science ®Google Scholar
• Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986; 38:321–416.
   PubMed Web of Science ®Google Scholar
• Graham RM, Perez DM, Hwa J, Piascik MT. α1-Adrenergic receptor subtypes, molecular structure, function and signaling. Cir Res 1996; 78:737–749.
   PubMed Web of Science ®Google Scholar
• Musha S, Watanabe M, Ishida Y, Kato S, Konishi M, Tomoda A. A phenoxazine compound, 2-amino-4, 4α-dihydro-4α-7-dimethyl-3H-phenoxazine-3-one reverses the phenylephrine or high-K+ induced contractions of smooth muscles in rat aorta and guinea-pig tenia cecum. Biol Pharm Bull 2005; 28:1521–1523.
   PubMed Web of Science ®Google Scholar
• Chan SS, Choi AO, Jones RL, Lin G. Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong in rat isolated aorta. Eur J Pharmacol 2006; 537:111–117.
   PubMed Web of Science ®Google Scholar
• Andreopouos S, Papapetropoulos A. Molecular aspects of soluble guanyl cyclase regulation. Gen Pharmacol 2000; 34:147–157.
   PubMedGoogle Scholar
• Thorin E, Huang PL, Fishman MC, Bevan JA. Nitric oxide inhibits alpha2-adrenoceptor-mediated endothelium-dependent vasodilation. Circ Res 1998; 82:1323–1329.
   PubMed Web of Science ®Google Scholar
• Korth M. Effects of several phosphodiesterase inhibitors on guinea-pig myocardium. Naunyn Schmiedebergs Arch Pharmacol 1978; 302:77–86.
   PubMed Web of Science ®Google Scholar
• Gilani AH, Khan A, Subhan F, Khan M. Antispasmodic and bronchodilator activities of St. John’s wort are putatively mediated through dual inhibition of calcium influx and phosphodiesterase. Fundam Clin Pharmacol 2005; 19:695–705.
   Google Scholar
• Tan YY, Summers RJ. β-Adrenoceptor regulation in rat heart, lungs and skin after chronic treatment with (-)-tertatolol or (-)-propranolol. J Auton Pharmacol 1995; 15:1149–1154.
   Google Scholar
• Hume JR, Grant AO. Agents used in cardiac arrhythmias. In: Katzung BG, ed. Basic and Clinical Pharmacology. 9th ed. New York: McGraw-Hill; 2004:216–236.
   Google Scholar
• Billman GE. The antiarrythmic effects of the calcium antagonists. In: Epstein M, ed. Calcium Antagonists in Clinical Medicine. Philadelphia: Hanley and Belfus Inc.; 1992:183–212.
   Google Scholar
• Hoffman BB. Therapy of hypertension. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman’s the Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill; 2006:845–868.
   Google Scholar
• Pietta P. Flavonoids in medicinal plants. In: Rive-Evans CV, Packer L, eds. Flavonoids in Health and Disease. New York: Marcel Dekker; 1998:61–110.
   Google Scholar